Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
|BReP-SNAP-M-76||From Fluence to Dose: Real-Time Adaptive MLC Tracking Using Dose Optimization|
L Mejnertsen1*, E Hewson1, D Nguyen1,2, J Booth3,4, P Keall1, (1) ACRF Image-X Institute, The University of Sydney, Camperdown, NSW, AU, (2) School of Biomedical Engineering, University of Technology Sydney, NSW, AU, (3) Royal North Shore Hospital, Sydney, NSW, AU, (4) Medical Physics, School of Physics, University of Sydney, Camperdown, NSW, AU.
|BReP-SNAP-M-100||Markerless Lung Tumour Tracking in the Beam-Eye-View for Modern VMAT Treatments|
R Tjang1, J Booth2,3, C Shieh1, V Caillet1,2, P Keall1, D Nguyen4,1*, (1) ACRF Image-X Institute, The University of Sydney, Sydney, Australia (2) Northern Sydney Cancer Center, St Leonard, NSW, Australia (3) School of Physics, The University of Sydney, Australia (4) School of Biomedical Engineering, University of Technology Sydney
|PO-GeP-I-138||Impact of Scanner Speed On the Rate of Radiologist Complaint of Motion Artifact On Pediatric Body CT|
M Lipford*, T Szczykutowicz, University Wisconsin-Madison, Madison, WI
|PO-GeP-M-61||Analysis of Varian RPM Reproducibility During Deep Inspiration Breath Hold with AlignRT Monitoring|
E Wright*, K Bota, S Karnas, S Gaede, London Regional Cancer Program, London, ON, CA
|PO-GeP-M-362||Real-Time Verification and Quantification of Breath-Hold Reproducibility During Treatment for Liver and Lung SBRT|
A Antolak*, N Woody, K Stephans, P Xia, B Guo, Cleveland Clinic Foundation, Cleveland, OH
|PO-GeP-T-637||Personalized Treatment Gating Thresholds in Frameless Stereotactic Radiosurgery Using Predictions of Dosimetric Fidelity and Treatment Interruption|
R MacDonald1*, Y Lee1, J Schasfoort2, H Soliman1, A Sahgal1, M Ruschin1(1) Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto, ON, CA,(2) Gamma Knife Center Tilburg
|TH-D-TRACK 6-3||Failure Mode and Effects Analysis of the Paraspinal Stereotactic Body Radiotherapy (SBRT) Program: Memorial Sloan Kettering Experience|
S Lee*, D Lovelock, A Kowalski, R Foley, M Gil, D Higginson, J Yamada, E Yorke, Memorial Sloan-Kettering Cancer Center, New York, NY
|TU-C-TRACK 1-6||Motion Artifact Impact On Dose Calculation Using CBCT|
S Scheib1*, I Peterlik2, P Paysan3, S Scheib4, Varian Medical Systems Imaging Laboratory, Daettwil Ag, CH,
|WE-F-TRACK 2-6||First in Human Use of Real-Time Target Tracking for Liver Cancer SABR On a Standard Linear Accelerator|
D Nguyen1,2*, T Moodie3, Y Lee4, A Kejda3, T Blacketer3, R O'Brien2, P Poulsen5, P Greer6, T Wang3, P Keall2, (1) School of Biomedical Engineering, University of Technology Sydney, Australia (2) ACRF Image-X Institute, The University of Sydney, Australia (3) Crown Princess Mary Cancer Center, Westmead, NSW, Australia (4) Princess Alexandira Hospital, Brisbane, Australia (5) Aarhus University Hospital, Aarhus, Denmark (6) Calvary Mater Newcastle Hospital, Newcastle, NSW, Australia